%D9%85%D9%8A%D8%AA%D9%81%D9%88%D8%B1%D9%85%D9%8A%D9%86%E0%A6%AE%E0%A7%87%E0%A6%9F%E0%A6%AB%E0%A6%B0%E0%A6%AE%E0%A6%BF%E0%A6%A8MetforminaCategory:MetforminMetfforminMetforminMetformin%CE%9C%CE%B5%CF%84%CF%86%CE%BF%CF%81%CE%BC%CE%AF%CE%BD%CE%B7MetforminMetformina%D9%85%D8%AA%D9%81%D9%88%D8%B1%D9%85%DB%8C%D9%86MetformiiniMetformine%D7%9E%D7%98%D7%A4%D7%95%D7%A8%D7%9E%D7%99%D7%9FMetformin%D5%84%D5%A5%D5%BF%D6%86%D5%B8%D6%80%D5%B4%D5%AB%D5%B6MetforminMetform%C3%ADnMetformina%E3%83%A1%E3%83%88%E3%83%9B%E3%83%AB%E3%83%9F%E3%83%B3%EB%A9%94%ED%8A%B8%ED%8F%AC%EB%A5%B4%EB%AF%BCMetform%C4%ABns%D0%9C%D0%B5%D1%82%D1%84%D0%BE%D1%80%D0%BC%D0%B8%D0%BD%E0%B4%AE%E0%B5%86%E0%B4%B1%E0%B5%8D%E0%B4%B1%E0%B5%8D%E0%B4%AB%E0%B5%8B%E0%B5%BC%E0%B4%AE%E0%B4%BF%E0%B5%BBMetformine%E0%AC%AE%E0%AD%87%E0%AC%9F%E0%AD%8D%E2%80%8C%E0%AC%AB%E0%AC%B0%E0%AD%8D%E0%AC%AE%E0%AC%BF%E0%AC%A8MetforminaMetforminaMetformin%C4%83%D0%9C%D0%B5%D1%82%D1%84%D0%BE%D1%80%D0%BC%D0%B8%D0%BDMetforminMetforminMetforminMetforminMetformin%E0%AE%AE%E0%AF%86%E0%AE%9F%E0%AF%8D%E0%AE%AA%E0%AE%BE%E0%AE%B0%E0%AF%8D%E0%AE%AE%E0%AE%BF%E0%AE%A9%E0%AF%8D%E0%B9%80%E0%B8%A1%E0%B8%95%E0%B8%9F%E0%B8%AD%E0%B8%A3%E0%B9%8C%E0%B8%A1%E0%B8%B4%E0%B8%99%D0%9C%D0%B5%D1%82%D1%84%D0%BE%D1%80%D0%BC%D1%96%D0%BDMetformin%E4%BA%8C%E7%94%B2%E5%8F%8C%E8%83%8D
about
sameAs
Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsJanagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With MetforminPharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy VolunteersWeight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential TherapyEfficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 DiabetesDurvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell CarcinomaComparison of the Effectiveness Metformin for Deceasing Proliferative Marker in Endometrial Cancer CellsInterventions Against Insulin Resistance in Pulmonary Arterial HypertensionOral Administration of Cinnamomum Cassia as an Enhancer of the Insulin Response of IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Treated With Metformin Diary.Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/SaxagliptinEffect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes MellitusDose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 DiabetesTargeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve GastrectomyA Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma PatientsEffect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin TherapyPRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic NephropathyAn Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release TabletsEfficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin MonotherapyA Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueVildagliptin 100 mg Once Daily vs. Placebo as add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With MetforminA Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 DiabetesEfficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic DrugsAcceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaEffects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL StudyEffects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With MetforminMetformin and Oral Contraceptives in PCOSEfficacy of Lifestyle Interventions and Metformin for the Treatment of Antipsychotic-Induced Weight GainSitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOSEffect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesA Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 DiabetesA Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.Beta-Cell Function and Sitagliptin Trial (BEST)Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DMEffect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance
P4844
response to metformindapagliflozin / metforminrosiglitazone / metforminalogliptin / metforminlinagliptin / metforminempagliflozin / metforminvildagliptin / metforminmetformin / saxagliptinAMP-activated Protein Kinase (AMPK) SignalingMetformin / pioglitazonecanagliflozin / Metforminertugliflozin / Metforminglyburide / metforminMATE substratesMATE substrates [extracellular region]OCT1 substratesOCT1 substrates [cytosol]OCT2 substratesOCT2 substrates [cytosol]trametinib / metformin combination therapySitagliptin/metforminHead and Neck Squamous Cell Carcinoma
P527
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsRisk of cancer in diabetes: the effect of metforminSulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysisMetformin: An UpdateMetformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 DiabetesIncidence of lactic acidosis in metformin usersEfficacy of metformin in the treatment of NIDDM. Meta-analysisMechanism by which metformin reduces glucose production in type 2 diabetesUse of metformin in the setting of mild-to-moderate renal insufficiencyMetformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHPEffect of Cephalexin on the Pharmacokinetics of Metformin in Healthy Human VolunteersClinical Pharmacokinetics of MetforminMetformin: new understandings, new uses.MetforminToxic Effects from Metformin ExposureMulticenter Case Series of Pediatric Metformin IngestionMechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*Metformin Treatment to Prevent Early Puberty in Girls with Precocious PubarcheThyrotropin Suppression by MetforminMetformin -- life begins at 50: A symposium held on the occasion of the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands, September 2007Adult metformin ingestions reported to Texas poison control centers, 2000-2006Role of AMP-activated protein kinase in mechanism of metformin actionMetformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?Metabolic actions of metformin in the heart can occur by AMPK-independent mechanismsMetformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentrationMetformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscleMetformin: safety in cardiac patientsThe antidiabetic gutsy role of metformin uncovered?Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trialContraindications to the use of metforminMetformin in polycystic ovary syndrome: systematic review and meta-analysisEffect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trialClomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysisReduction of metformin renal tubular secretion by cimetidine in manMetformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trialExtracorporeal Treatment for Metformin PoisoningMetformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indicationsA fatal case of metformin poisoning.Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary SyndromeReduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Metfformin
@cy
Metformiini
@fi
Metformin
@da
Metformin
@de
Metformin
@en-ca
Metformin
@hu
Metformin
@id
Metformin
@sh
Metformin
@sl
Metformin
@sq
type
label
Metfformin
@cy
Metformiini
@fi
Metformin
@da
Metformin
@de
Metformin
@en-ca
Metformin
@hu
Metformin
@id
Metformin
@sh
Metformin
@sl
Metformin
@sq
altLabel
1,1-Dimethyl biguanide
@en
1,1-Dimethylbiguanide
@en
1-carbamimidamido-N,N-dimethylmethanimidamide
@en
1115-70-4
@fr
657-24-9
@fr
C4H11N5
@fr
DMBG
@en
Diabefagos
@en
Diabex
@en
Diaformin
@en
prefLabel
Metfformin
@cy
Metformiini
@fi
Metformin
@da
Metformin
@de
Metformin
@en-ca
Metformin
@hu
Metformin
@id
Metformin
@sh
Metformin
@sl
Metformin
@sq